Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Low-dose nivolumab with neoadjuvant chemotherapy and oral metronomic therapy in borderline resectable oral cavity squamous cell carcinoma: a phase II trial.

The Lancet regional health. Southeast Asia·2026
Same author

Cytogenetic Profile of Newly Diagnosed Acute Myeloid Leukemia Patients: Insights from a Study at a Tertiary Care Centre in South India.

Asian Pacific journal of cancer prevention : APJCP·2026
Same author

Expression of Programmed Death Ligand 1 (PD-L1) in Classical Hodgkin Lymphoma- Study from a Tertiary Care Cancer Centre in South India.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2026
Same author

Telangiectatic Osteosarcoma-A Single-Center Experience.

South Asian journal of cancer·2025
Same author

Management and survival outcomes of desmoplastic small round cell tumor: a retrospective cohort study from a tertiary cancer center.

BMC cancer·2025
Same author

Real world outcomes with Tepotinib in a series of Indian patients with MET exon 14 skipping positive non-small cell lung cancer.

Ecancermedicalscience·2025

相关实验视频

Updated: Jul 11, 2025

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

12.0K

卡斯特曼病:来自单一机构的经验

Sherry S Abraham1, Geetha Narayanan1, Sugeeth Mangalapilly Thambi1

  • 1Department of Medical Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala 695011, India.

Medicine international
|November 6, 2023
PubMed
概括

卡斯特曼病 (CD) 是一种罕见的淋巴增殖性疾病. 单中心性CD (UCD) 通过手术显示出更好的结果,而多中心性CD (MCD) 则需要化疗,观察到91%的3年生存率.

关键词:
卡斯特曼病是什么?卡斯特曼病是什么?人类免疫缺陷病毒-阴性.多中心的多中心.单心的 单心的 单心的

更多相关视频

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

14.8K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K

相关实验视频

Last Updated: Jul 11, 2025

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

12.0K
Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

14.8K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 罕见疾病 罕见疾病

背景情况:

  • 卡斯特曼病 (Castleman disease,简称CD) 是一种罕见的,异质的淋巴增殖性疾病,其特征是淋巴结扩大.
  • CD被广泛分为单心 (UCD) 和多心 (MCD) 形式.

研究的目的:

  • 以回顾分析2017年至2022年间被诊断患有卡斯特曼病的11名患者的临床数据.
  • 评估UCD和MCD亚型的治疗策略和结果.

主要方法:

  • 来自第三级癌症中心的患者数据的回顾性审查.
  • 对11名CD患者 (7名UCD,4名MCD) 的人口统计,组织学,治疗和生存数据的分析.

主要成果:

  • 在UCD和MCD中,氨酸-血管变异是主要的组织学.
  • 经过手术治疗的UCD患者获得了高响应率 (6个完整,1个部分).
  • 患有MCD的患者接受了包括rituximab和化疗 (RCHOP/CHOP) 在内的全身疗法,反应不同,死亡1例.

结论:

  • 卡斯特曼病是一种罕见的疾病,UCD更为普遍,预后较好.
  • 手术切除是UCD的主要治疗方法,产生了很好的结果.
  • MCD需要全身治疗,通常涉及组合化疗,并且与UCD相比,存活率较低.